1nhaler raises £2.2m to take pop-up dry-powder inhaler to the clinic

1nhaler, a developer of dry-powder inhalers (DPIs), raised £2.2 million in funding to advance toward regulatory filing planned for 2027. The capital will support clinical development of the company's pop-up inhaler technology, positioning it for market entry in the coming years.